Abstract
Botulinum toxin therapy (BTT), originally applied to treat strabism (for review see [8]), is now established as a minimally invasive, successful therapy in a number of diseases. The treatment of mass movements (synkinesis) following paralysis of the facial nerve, which may have various etiologies, has recently been reported as another indication. First experiences with BTT, applied to several patients with such synkinesis, were published by Roggenkämper et al. [7]. This indication was also confirmed by case reports by other authors [2, 6]. According to Roggenkämper et al. [7] this treatment is effective for an average of 11 weeks after the first injection, according to patients’ personal assessment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brudny J, Hammerschlag PE, Cohen NL, Ransohof J., (1988) Electromyographic rehabilitation of facial function and introduction of a facial paralysis grading scale for hypoglossal-facial nerve anastomosis. Laryngoscope 98: 405–410
Dressler D, Schönle PW., (1990) Botulinum toxin to suppress hyperkinesias after hypoglossal-facial nerve anastomosis. Eur Arch Otorhinolaryngol 247: 391–392
Fisch U., (1986) Extracranial surgery for facial hyperkinesis. In: May M., (ed) The facial nerve. Thieme, Stuttgart, chapter 27, pp 509–523
Fowler EP., (1939) Abnormal movements following injury to the facial nerve. J AMA 1003–1008
Lamy H., (1905) Note sur les contractions “synergiques paradoxales” observé ä suite de la paralysie faciale périphériques. Nouv Iconogr Salpetr 18: 424–425
Putterman AM., (1990) Botulinum toxin injections in the treat-ment of seventh nerve misdirection. Am J Opthalmol 205–206
Roggenkämper P, Laskawi R, Damenz W, Schröder M, Nüßgens Z., (1990) Botulinus-Toxin-Behandlung bei Synkinesien nach Fazialisparese. HNO 38: 295–297
Scott AB., (1989) Botulinum-toxin therapy of eye muscle dis-orders. Safety and effectiveness (ophthalmic procedures assessment, American Academy of Ophthalmology ). Ophthalmology, instrument and book issue
Shimono T, Hattori N, Yamamoto T, Takimoto I., (1989) EMG- biofeedback therapy for reduction of synkinesis. Facial N Res Jpn 9: 189–192
Stennert E, Limberg CH, Frentrup KL (1977) Parese und Defektheilungsinder — ein leicht anwendbares Schema zur Objektivierung und Bewertung von Therapieerfolgen bei Fazialisparesen. HNO 25: 238–245
Stennert E., (1981) Komplikationen und Rückstände nach operativen Eingriffen am Nervus facialis. In: Miehlke A, Stennert E, Arold R., Motorische Nerven. Arch Ohren Nasen Kehlkopfheilkd, 231, (1 TA)
Stennert E., (1982) Das autoparalytische Syndrom — ein Leit-symptom der postparetischen Fazialisfunktion. Arch Otorhinolaryngol 236: 97–114
Sunderland S., (1977) Mass movement after facial nerve injury. In: Fisch M., (ed) Facial nerve surgery. Kugler, Amstelveen, pp 285–289
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag
About this paper
Cite this paper
Laskawi, R., Damenz, W., Roggenkämper, P., Baetz, A. (1994). Botulinum Toxin Treatment in Patients with Facial Synkinesis. In: Stennert, E.R., Kreutzberg, G.W., Michel, O., Jungehülsing, M. (eds) The Facial Nerve. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85090-5_70
Download citation
DOI: https://doi.org/10.1007/978-3-642-85090-5_70
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-57686-0
Online ISBN: 978-3-642-85090-5
eBook Packages: Springer Book Archive